Health authorities at Taoyuan International Airport have identified the first imported case of the SARS-CoV-2 BA.3.2 variant through a voluntary saliva surveillance programme for symptomatic arriving passengers. The case involves a 10-year-old female Singaporean national who arrived in Taiwan for a holiday on 14 March 2026. Upon arrival, the child was flagged by the Centers for Disease Control (CDC) quarantine station after thermal scanners detected a fever of 38.5°C, prompting a mechanical necessity for immediate medical evaluation.
The young traveller, who had spent the entire 14-day period prior to her trip in Singapore, voluntarily provided a saliva sample for genomic sequencing at the CDC’s Research and Diagnostic Center. Following a thorough review of her Travel, Occupation, Contact, and Cluster (TOCC) history, quarantine officers discovered that the girl had not received any COVID-19 vaccinations within the last 12 months. In addition to the coronavirus screening, officials also conducted serum testing for dengue fever as a precautionary measure before issuing a 24-hour medical consultation notice.
The patient’s visit to Taiwan was brief, spanning from 14 March to 20 March, and she has since departed the country. While the BA.3.2 variant is a new discovery for the airport’s surveillance team, the World Health Organization (WHO) has reassured the public that current vaccines continue to offer robust protection against severe illness from this specific strain. The CDC has reiterated its call for high-risk groups to stay updated with their vaccinations, as it remains the most effective method for preventing hospitalisation.
In a related regional health update, authorities noted that while overall COVID-19 trends in Japan are currently declining, the situation in Okinawa remains a point of concern. Between the 9th and 12th weeks of the year, infection rates in Okinawa surged by 1.2 times, with the average number of reported cases per clinic rising from 1.56 to 3.47. Okinawa currently holds the second-highest infection rate in Japan, surpassed only by Iwate Prefecture, though specific variant data for the island remains unavailable at the sub-national level.
Currently, the dominant strain circulating throughout Japan is the NB.1.8.1 variant. Despite the localized spike in Okinawa, international health experts maintain that the overall global risk assessment for these emerging sub-variants remains stable. Travellers are advised to monitor their health closely and utilise voluntary testing services at international gateways to assist in the early detection and monitoring of new viral mutations as global tourism continues to fluctuate.
